Application Deadline: 
Thursday, January 31, 2019
Applicants for this Fellowship must have a strong bioengineering background. Bioengineering is an interdisciplinary field that applies physical, chemical, and mathematical sciences, and engineering principles to the study of biology, medicine, behavior, and health. It advances knowledge from the molecular to the organ levels, and develops new and novel biologically derived medications and devices, materials processes, implants, and informatics approaches for the prevention, diagnosis, and treatment of disease, for patient rehabilitation, and for improving health. Bioengineers have employed mechanical engineering principles in the development of many life-saving and life-improving technologies, such as the artificial heart, prosthetic joints, diagnostics, and numerous rehabilitation technologies. In addition, new emerging areas such as nanotechnology and biomanufacturing, require significant contributions from bioengineers. While total health-related US research and development investments have expanded significantly over the last decade, investment in bioengineering at NIH institutes like the NIBIB has remained relatively flat over the last several years; when in many instances, bioengineering-based solutions to health care problems can result in improved health outcomes and reductions in health care costs. ASME has long been concerned about the level of bioengineering investments and the need to increase bioengineering expertise within the NIBIB and across NIH and the federal government, including Congress.